GT Biopharma annual gross margin
2010
2011
2012
2013
2014
2015
GT Biopharma's gross margin was 100.00% for fiscal 2015.
View full GT Biopharma company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2015 | 2015-12-31 | 100.00% | +93.44 pp |
| 2014 | 2014-12-31 | 6.56% | −32.03 pp |
| 2013 | 2013-12-31 | 38.59% | −33.93 pp |
| 2012 | 2012-12-31 | 72.51% | +157.13 pp |
| 2011 | 2011-12-31 | −84.62% | +406.29 pp |
| 2010 | 2010-12-31 | −490.91% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2015 | 2015-06-30 | 100.00% | +68.00 pp |
| Q1 2015 | 2015-03-31 | 100.00% | +67.21 pp |
| Q4 2014 | 2014-12-31 | −6.06% | −38.85 pp |
| Q3 2014 | 2014-09-30 | −66.67% | −88.26 pp |
| Q2 2014 | 2014-06-30 | 32.00% | −40.27 pp |
| Q3 2013 | 2013-09-30 | 32.79% | −40.55 pp |
| Q2 2013 | 2013-06-30 | 32.79% | −67.21 pp |
| Q1 2013 | 2013-03-31 | 21.59% | +21.59 pp |
| Q4 2012 | 2012-12-31 | 72.27% | −27.73 pp |
| Q3 2012 | 2012-09-30 | 73.33% | +373.33 pp |
| Q2 2012 | 2012-06-30 | 100.00% | +1500.00 pp |
| Q1 2012 | 2012-03-31 | 0.00% | +25.00 pp |
| Q4 2011 | 2011-12-31 | 100.00% | — |
| Q3 2011 | 2011-09-30 | −300.00% | — |
| Q2 2011 | 2011-06-30 | −1,400.00% | — |
| Q1 2011 | 2011-03-31 | −25.00% | — |
Over the last five reported fiscal years, GT Biopharma's gross margin increased from −490.91% to 100.00%, a change of +590.91 percentage points. The latest reported quarter, Q2 2015, shows 100.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GT Biopharma filings at SEC.gov ↗